⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18186790 | 0.90 | TSHR (0.40) | — | |
| SCHEMBL11200 | 0.77 | TSHR (0.35) | — | |
| SCHEMBL1260831 | 0.74 | — | — | |
| SCHEMBL3889936 | 0.74 | TSHR (0.33) | — | |
| SCHEMBL1064342 | 0.74 | — | — | |
| SCHEMBL17865466 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL1567062 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL14997895 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL1395981 | 0.72 | — | — | |
| SCHEMBL7934263 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1560579-A1 | CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | SCHERING CORPORATION (US) | 2005-08-10 | — | — | EP | claimed |
| WO-2004043457-A1 | CHOLESTEROL ABSORPTIONS INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | SCHERING CORPORATION (US) | 2004-05-27 | — | — | WO | claimed |
| EP-0596015-A1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF. | SCHERING CORP (US) | 1994-05-11 | — | — | EP | claimed |
| WO-1993002048-A1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF | SCHERING CORPORATION (US) | 1993-02-04 | — | — | WO | claimed |
| WO-2023176458-A1 | DISINFECTING COMPOSITION CONTAINING THIAZOLE CARBOXYLIC ACID HYDRAZIDE COMPOUND | 石原産業株式会社 | 2023-09-21 | — | — | WO | disclosed |
| WO-2020189525-A1 | HETEROCYCLIC COMPOUND AND AGRICULTURAL OR HORTICULTURAL BACTERICIDE | 日本曹達株式会社 | 2020-09-24 | — | — | WO | disclosed |
| EP-3672939-A1 | PROCESSES FOR PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE | Celgene Corporation (US) | 2020-07-01 | — | — | EP | disclosed |
| WO-2020008382-A1 | PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF | DR. REDDY’S LABORATORIES LIMITED (IN) | 2020-01-09 | — | — | WO | disclosed |
| WO-2019040109-A1 | PROCESSES FOR PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE | CELGENE CORPORATION (US) | 2019-02-28 | — | — | WO | disclosed |
| EP-2882769-A2 | SYNTHESIS OF DEUTERATED RIBO NUCLEOSIDES, N-PROTECTED PHOSPHORAMIDITES, AND OLIGONUCLEOTIDES | Ased, LLC (US) | 2015-06-17 | — | — | EP | disclosed |
| EP-2882768-A2 | SYNTHESIS OF DEUTERATED RIBO NUCLEOSIDES, N-PROTECTED PHOSPHORAMIDITES, AND OLIGONUCLEOTIDES | Ased, LLC (US) | 2015-06-17 | — | — | EP | disclosed |
| EP-2386558-B1 | CGRP antagonists | BOEHRINGER INGELHEIM INT (DE) | 2014-10-01 | — | — | EP | disclosed |
| EP-0934065-A1 | PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998024780-A2 | SUBSTITUTED PYRIMIDINONE AND PYRIDINONE COMPOUNDS AND THEIR USE | AMGEN INC. (US) | 1998-06-11 | — | — | WO | disclosed |
| WO-1998024782-A2 | SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE | AMGEN INC. (US) | 1998-06-11 | — | — | WO | disclosed |
| WO-1998008505-A1 | PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0596015-A1 | SUBSTITUTED BETA-LACTAM COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS AND PROCESSES FOR THE PREPARATION THEREOF. | SCHERING CORP (US) | 1994-05-11 | — | — | EP | disclosed |
| EP-0182213-B1 | CARBAPENEM COMPOUNDS AND PRODUCTION THEREOF | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1990-09-26 | — | — | EP | disclosed |
| EP-0153822-B1 | METHOD FOR PREPARING CIS-BICYCLO(3.3.0)OCTYLIDENE DERIVATIVE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1990-05-23 | — | — | EP | disclosed |
| EP-0134153-B1 | Bicyclo[3.3.0]octane derivative and preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-04-19 | — | — | EP | disclosed |